LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Six Months of British Cancer Research Organization’s Genetic Data Decoded in One Month by Smartphone Gamers

By LabMedica International staff writers
Posted on 23 Mar 2014
In just one month, “citizen scientists” have studied DNA data that would have taken a scientist six months to analyze by eye by playing a new smartphone game Play to Cure: Genes in Space.

If this amount of DNA was stretched out, it would stretch across 65 km. Amazingly, this is a distance equivalent to the length of more than 80 times the height of the Burj Khalifa in Dubai, the world’s tallest building.

These figures follow the February 2014 launch of the playing Cancer Research UK’s (London, UK) novel game, which global gamers of all ages can play on their smartphones and simultaneously analyze gene data. Cancer Research UK’s scientists must interpret huge amounts of information to find cancer-causing genetic defects in develop new targeted therapies for patients. However, the human eye is required to locate patterns in the data--computers are not effective enough. Furthermore, it would take scientists a long time to do this manually—sidetracking their time from other vital research.

But the collective power of the sheer numbers of gamers worldwide have sped this up, and will increase accuracy with many pairs of eyes examining each stretch of DNA. In just one month, there have been 1.5 million classifications through the game from players in almost every country in world. Furthermore, citizen scientists have collectively devoted more than 53,000 hours—six and a half years—playing the game and analyzed approximately 50% of the data from the first research project.

Hannah Keartland, Cancer Research UK's citizen science lead, said, “We’re astounded by this fantastic support from citizen scientists across the world which goes to show—you don’t need to wear a lab coat to be a hero. “It’s crucial we don’t stop here because the more people who play in their spare moments, the quicker we’ll make a difference. There never again needs to be such a thing as a boring queue. It’s still early days but we believe the collective force of global gamers could have a massive impact and speed up our life-saving research.”

Prof. Carlos Caldas, senior group leader at the Cancer Research UK Cambridge Institute, University of Cambridge (UK), said, “We’re incredibly grateful to everyone who is giving their spare moments to help us analyze genetic data. We’re working hard to develop better drugs, improve the diagnosis of cancer patients and understand why some treatments work and others won’t—to spare unpleasant side effects. Computers can’t analyze our research data with 100% accuracy—we need the human eye for greater precision. It can take us years to decode the huge amounts of data generated by research. But with everyone’s help the boost to our work could be enormous.”

The game is available to download now for free for anyone with an Android or Apple Smartphone.

Related Links:

Cancer Research UK 


New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hematology Analyzer
Medonic M32B
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more